Cytosorbents Corporation CTSO
$5.75
$0.020.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.42M | -5.13M | -5.50M | -3.17M | 1.95M |
| Total Depreciation and Amortization | 376.00K | 376.00K | 385.00K | 401.00K | 440.00K |
| Total Amortization of Deferred Charges | 282.00K | 291.00K | 249.00K | 190.00K | 191.00K |
| Total Other Non-Cash Items | 1.58M | 2.05M | 1.20M | 736.00K | -5.35M |
| Change in Net Operating Assets | 1.59M | 1.26M | -1.17M | -734.00K | 1.27M |
| Cash from Operations | -583.00K | -1.16M | -4.83M | -2.58M | -1.51M |
| Capital Expenditure | -14.00K | -11.00K | -108.00K | -17.00K | -37.00K |
| Sale of Property, Plant, and Equipment | 59.00K | 26.00K | 76.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.00K | -61.00K | -259.00K | 72.00K | -95.00K |
| Cash from Investing | 7.00K | -46.00K | -291.00K | 55.00K | -132.00K |
| Total Debt Issued | -- | -- | 2.48M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 2.48M | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | 176.00K | -228.00K | 1.35M | -146.00K | 257.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -400.00K | -1.44M | -1.29M | -2.67M | -1.38M |